全文获取类型
收费全文 | 5923篇 |
免费 | 425篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 47篇 |
儿科学 | 242篇 |
妇产科学 | 137篇 |
基础医学 | 953篇 |
口腔科学 | 53篇 |
临床医学 | 632篇 |
内科学 | 1165篇 |
皮肤病学 | 62篇 |
神经病学 | 690篇 |
特种医学 | 148篇 |
外科学 | 608篇 |
综合类 | 39篇 |
预防医学 | 635篇 |
眼科学 | 55篇 |
药学 | 471篇 |
中国医学 | 26篇 |
肿瘤学 | 408篇 |
出版年
2024年 | 6篇 |
2023年 | 36篇 |
2022年 | 70篇 |
2021年 | 166篇 |
2020年 | 96篇 |
2019年 | 153篇 |
2018年 | 169篇 |
2017年 | 129篇 |
2016年 | 144篇 |
2015年 | 172篇 |
2014年 | 197篇 |
2013年 | 302篇 |
2012年 | 417篇 |
2011年 | 486篇 |
2010年 | 256篇 |
2009年 | 238篇 |
2008年 | 405篇 |
2007年 | 415篇 |
2006年 | 387篇 |
2005年 | 381篇 |
2004年 | 373篇 |
2003年 | 343篇 |
2002年 | 319篇 |
2001年 | 44篇 |
2000年 | 27篇 |
1999年 | 42篇 |
1998年 | 67篇 |
1997年 | 60篇 |
1996年 | 59篇 |
1995年 | 40篇 |
1994年 | 38篇 |
1993年 | 37篇 |
1992年 | 27篇 |
1991年 | 24篇 |
1990年 | 18篇 |
1989年 | 19篇 |
1988年 | 16篇 |
1987年 | 17篇 |
1986年 | 13篇 |
1985年 | 12篇 |
1984年 | 23篇 |
1983年 | 13篇 |
1982年 | 17篇 |
1981年 | 14篇 |
1980年 | 21篇 |
1979年 | 12篇 |
1978年 | 12篇 |
1977年 | 6篇 |
1976年 | 8篇 |
1973年 | 5篇 |
排序方式: 共有6371条查询结果,搜索用时 15 毫秒
71.
Chan K Shaw D Simmonds MS Leon CJ Xu Q Lu A Sutherland I Ignatova S Zhu YP Verpoorte R Williamson EM Duez P 《Journal of ethnopharmacology》2012,140(3):469-475
Ethnopharmacological relevance
Studies on traditional Chinese medicine (TCM), like those of other systems of traditional medicine (TM), are very variable in their quality, content and focus, resulting in issues around their acceptability to the global scientific community. In an attempt to address these issues, an European Union funded FP7 consortium, composed of both Chinese and European scientists and named “Good practice in traditional Chinese medicine” (GP-TCM), has devised a series of guidelines and technical notes to facilitate good practice in collecting, assessing and publishing TCM literature as well as highlighting the scope of information that should be in future publications on TMs. This paper summarises these guidelines, together with what has been learned through GP-TCM collaborations, focusing on some common problems and proposing solutions. The recommendations also provide a template for the evaluation of other types of traditional medicine such as Ayurveda, Kampo and Unani.Materials and methods
GP-TCM provided a means by which experts in different areas relating to TCM were able to collaborate in forming a literature review good practice panel which operated through e-mail exchanges, teleconferences and focused discussions at annual meetings. The panel involved coordinators and representatives of each GP-TCM work package (WP) with the latter managing the testing and refining of such guidelines within the context of their respective WPs and providing feedback.Results
A Good Practice Handbook for Scientific Publications on TCM was drafted during the three years of the consortium, showing the value of such networks. A “deliverable – central questions – labour division” model had been established to guide the literature evaluation studies of each WP. The model investigated various scoring systems and their ability to provide consistent and reliable semi-quantitative assessments of the literature, notably in respect of the botanical ingredients involved and the scientific quality of the work described. This resulted in the compilation of (i) a robust scoring system and (ii) a set of minimum standards for publishing in the herbal medicines field, based on an analysis of the main problems identified in published TCM literature.Conclusion
Good quality, peer-reviewed literature is crucial in maintaining the integrity and the reputation of the herbal scientific community and promoting good research in TCM. These guidelines provide a clear starting point for this important endeavour. They also provide a platform for adaptation, as appropriate, to other systems of traditional medicine. 相似文献72.
Anne-Esther Breyton Aurélie Goux Stéphanie Lambert-Porcheron Alexandra Meynier Monique Sothier Laurie VanDenBerghe Olivier Brack Emmanuel Disse Martine Laville Sophie Vinoy Julie-Anne Nazare 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2021,31(1):237-246
Background and aimsIn type 2 diabetes (T2D) patients, the reduction of glycemic variability and postprandial glucose excursions is essential to limit diabetes complications, beyond HbA1c level. This study aimed at determining whether increasing the content of Slowly Digestible Starch (SDS) in T2D patients’ diet could reduce postprandial hyperglycemia and glycemic variability compared with a conventional low-SDS diet.Methods and resultsFor this randomized cross-over pilot study, 8 subjects with T2D consumed a controlled diet for one week, containing starchy products high or low in SDS. Glycemic variability parameters were evaluated using a Continuous Glucose Monitoring System.Glycemic variability was significantly lower during High-SDS diet compared to Low-SDS diet for MAGE (Mean Amplitude of Glycemic Excursions, p < 0.01), SD (Standard Deviation, p < 0.05), and CV (Coefficient of Variation, p < 0.01). The TIR (Time In Range) [140–180 mg/dL[ was significantly higher during High-SDS diet (p < 0.0001) whereas TIRs ≥180 mg/dL were significantly lower during High-SDS diet. Post-meals tAUC (total Area Under the Curve) were significantly lower during High-SDS diet.ConclusionOne week of High-SDS Diet in T2D patients significantly improves glycemic variability and reduces postprandial glycemic excursions. Modulation of starch digestibility in the diet could be used as a simple nutritional tool in T2D patients to improve daily glycemic control.Registration numberin clinicaltrials.gov: NCT 03289494. 相似文献
73.
74.
75.
Social Role Participation and Satisfaction With Life: A Study Among Patients With Ankylosing Spondylitis and Population Controls 下载免费PDF全文
Simon van Genderen Guy Plasqui Désirée van der Heijde Floris van Gaalen Liesbeth Heuft Jolanda Luime Anneke Spoorenberg Suzanne Arends Diane Lacaille Monique Gignac Robert Landewé Annelies Boonen 《Arthritis care & research》2018,70(4):600-607
Objective
Participation in society of persons with chronic diseases receives increasing attention. However, little is known about which components of participation are most relevant to life satisfaction. This study examines the association between several aspects of social role participation and satisfaction with life (SWL) in patients with ankylosing spondylitis (AS) compared to population controls.Methods
In a cross‐sectional study, participants completed the Social Role Participation Questionnaire (SRPQ) and SWL scale. The SRPQ assesses several dimensions of participation (importance, satisfaction with performance, and satisfaction with time and physical difficulty) in 11 roles representing 3 domains (interpersonal relations, leisure, and work). For individuals with AS and controls, the association between role domains and SWL was examined using linear regression for each participation dimension separately, in the total and the employed population, adjusting for age, sex, education, and income.Results
A total of 246 AS patients (mean ± SD age 51 ± 12 years, 62% males, mean ± SD disease duration 17 ± 12 years) and 510 controls (mean ± SD age 42 ± 15 years, 70% males) were included. AS patients were more frequently (extremely) dissatisfied with life (17.9% versus 8.6%; P < 0.05). In the total and the employed population, less physical difficulty and higher satisfaction with interpersonal relations and leisure were associated with higher SWL, and this was somewhat stronger in patients than in controls (P < 0.1). In employed controls, but not in employed patients, satisfaction with work was independently associated with SWL.Conclusion
These findings highlight the importance of supporting persons with AS in ameliorating social role participation, particularly in areas like close relationships and leisure activities, which are typically ignored when treating AS.76.
77.
78.
79.
Soulié C Malet I Lambert-Niclot S Tubiana R Thévenin M Simon A Murphy R Katlama C Calvez V Marcelin AG 《AIDS (London, England)》2008,22(16):2212-2214
Resistance to CCR5 antagonists can be driven by mutations in gp120. Sequences from 323 anti-CCR5 naive patients were analyzed for the presence of previously described in-vivo or in-vitro resistance mutations to CCR5 antagonists located in the V3 loop of gp120. The V3 loop region was rather polymorphic, and 7.3% of patients showed viruses with combinations of mutations in V3 loop previously described to be involved in maraviroc resistance, a licensed CCR5 antagonist. 相似文献
80.